Related Experiment Video

Updated: May 17, 2026

A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers
10:49

A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers

Published on: September 26, 2019

Flavopiridol inhibits interferon-γ-induced nitric oxide production in mouse vascular endothelial cells

Tsuguaki Terashima1, Abedul Haque, Yuka Kajita

  • 1Departments of Emergency Medicine, Aichi Medical University School of Medicine, Nagakute, Aichi 480-1195, Japan.

Immunology Letters
|October 18, 2012
PubMed

Insights

Flavopiridol (FP) inhibits interferon-gamma-induced nitric oxide production in endothelial cells by blocking the STAT1 signaling pathway. This suggests FP

Area of Science:

  • Immunology
  • Molecular Biology
  • Pharmacology

Background:

  • Interferon-gamma (IFN-γ) induces nitric oxide (NO) production in vascular endothelial cells, a process implicated in inflammation and cancer.
  • Cyclin-dependent kinase inhibitors, such as Flavopiridol (FP), are investigated for their anti-cancer properties and potential immunomodulatory effects.

Purpose of the Study:

  • To investigate the effect of Flavopiridol (FP) on IFN-γ-induced nitric oxide (NO) production in mouse vascular endothelial cells (END-D).
  • To elucidate the molecular mechanisms underlying FP's action on IFN-γ signaling and NO synthesis.

Main Methods:

  • Treatment of END-D cells with FP and IFN-γ.
  • Measurement of NO production.
  • Analysis of inducible NO synthase (iNOS) expression.
  • Assessment of STAT1 and IRF1 activation.
  • Evaluation of IFN-γ receptor expression.

Main Results:

  • FP significantly inhibited IFN-γ-induced NO production in END-D cells.
  • FP reduced the expression of inducible NO synthase (iNOS).
  • FP inhibited the activation of STAT1 and its downstream target IRF1.
  • FP did not affect the cell surface expression of the IFN-γ receptor.

Conclusions:

  • Flavopiridol inhibits IFN-γ-induced NO production in vascular endothelial cells by interfering with intracellular IFN-γ signaling.
  • FP acts by preventing the activation of STAT1 and IRF1, crucial components of the IFN-γ pathway.
  • FP demonstrates potential as both an immunomodulatory and anti-cancer agent.

More Related Videos

Imaging of In Situ Interferon Gamma Production in the Mouse Spleen following Listeria monocytogenes Infection09:11

Imaging of In Situ Interferon Gamma Production in the Mouse Spleen following Listeria monocytogenes Infection

Published on: July 16, 2019

Rescue of Recombinant Newcastle Disease Virus from cDNA10:55

Rescue of Recombinant Newcastle Disease Virus from cDNA

Published on: October 11, 2013

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...